A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
for Macular Degeneration
51 locations incl. Scottsdale
Sponsor: EyeBiotech Ltd.
Sex: All·Age: 50+
Code: NCT07440225·Phase 2, Phase 3·Recruiting·Listed Feb 2026
Cumberland Valley Retina Consultants PC
Clinical research site in Hagerstown, Maryland · 1800 DUAL HWY STE 201, HAGERSTOWN, MD 21740-6636 · (301) 665-1712
As of July 2026, 15 paid clinical trials are recruiting at Cumberland Valley Retina Consultants PC in Hagerstown, Maryland. Active studies at this site cover conditions such as Macular Edema Secondary to Inflammation, Diabetic Retinopathy and Diabetic Retinopathy, DR. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Cumberland Valley Retina Consultants PC (15)
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for Geographic Atrophy Secondary to Age-related Macular Degeneration
78 locations incl. Gilbert
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All·Age: 60+
Code: NCT07215390·Phase 2·Recruiting·Listed Oct 2025
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
for Age-related Macular Degeneration (AMD)
140 locations incl. Chandler
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 50 - 85
Code: NCT06541704·Phase 3·Recruiting·Listed Aug 2024
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for Geographic Atrophy
45 locations incl. Tucson
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 60+
Code: NCT06635148·Phase 2·Recruiting·Listed Oct 2024
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for Macular Edema Secondary to Inflammation
53 locations incl. Phoenix
Sponsor: Kodiak Sciences Inc
Sex: All·Age: 18+
Code: NCT06996080·Phase 3·Recruiting·Listed May 2025
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for Macular Edema Secondary to Inflammation
53 locations incl. Phoenix
Sponsor: Kodiak Sciences Inc
Sex: All·Age: 18+
Code: NCT06990399·Phase 3·Recruiting·Listed May 2025
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
for Geographic Atrophy
54 locations incl. Phoenix
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: All ages
Code: NCT06779773·Recruiting·Listed Jan 2025
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
for Neovascular Age-Related Macular Degeneration (nAMD)
54 locations incl. Scottsdale
Sponsor: 4D Molecular Therapeutics
Sex: All·Age: 50+
Code: NCT07064759·Phase 3·Recruiting·Listed Jul 2025
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for Geographic Atrophy
15 locations incl. Peoria
Sponsor: Sanofi
Sex: All·Age: 60+
Code: NCT07215234·Phase 1, Phase 2·Recruiting·Listed Oct 2025
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
for Macular Edema
23 locations incl. Arcadia
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06962839·Phase 2·Recruiting·Listed May 2025
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
for Neovascular (Wet) Age-Related Macular Degeneration
19 locations incl. Phoenix
Sponsor: 4D Molecular Therapeutics
Sex: All·Age: 50+
Code: NCT05197270·Phase 1, Phase 2·Recruiting·Listed Jan 2022
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
for Neovascular Age-Related Macular Degeneration (nAMD)
8 locations incl. Bakersfield
Sponsor: Ocular Therapeutix, Inc.
Sex: All·Age: 50+
Code: NCT07516132·Phase 3·Recruiting·Listed Apr 2026
A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy
for Non-Proliferative Diabetic Retinopathy
1 location in Hagerstown
Sponsor: Ocular Therapeutix, Inc.
Sex: All·Age: 18+
Code: NCT07235085·Phase 3·Recruiting·Listed Nov 2025
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
for Geographic Atrophy of the Macula
3 locations incl. Beverly Hills
Sponsor: Galimedix Therapeutics Inc
Sex: All·Age: 55+
Code: NCT06659549·Phase 2·Recruiting·Listed Oct 2024
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
for Diabetic Retinopathy
8 locations incl. Beverly Hills
Sponsor: Vantage Biosciences Ltd
Sex: All·Age: 18+
Code: NCT06770933·Phase 2·Recruiting·Listed Jan 2025
More research sites in Hagerstown
- Cumberland Valley Retina Consultants (11 trials)
- Mid Atlantic Retina Specialists (4 trials)
- Cumberland Valley Retina Consultants,P.C. (2 trials)
- Klein & Associates, M.D., P.A. (2 trials)
- Mid Atlantic Retina Specialist (2 trials)
- Adverum Clinical (2 trials)
- Mid Atlantic Retina Specialists - Hagerstown (2 trials)
- ADARx Clinical Site (1 trial)
- Cumberland Valley Retina Associates (1 trial)
- Cumberland Valley Retina Consultants (CVRC) (1 trial)
Explore more
Paid clinical trials in Hagerstown, MD · Maryland clinical trials